Abiomed Price/Sales
Cos'è Price/Sales di Abiomed?
Price/Sales di Abiomed Inc. è 16.10
Qual è la definizione di Price/Sales?
Il rapporto prezzo / vendite è il prezzo delle azioni di una società rispetto ai suoi ricavi.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales di aziende nel Health Care settore su NASDAQ rispetto a Abiomed
Cosa fa Abiomed?
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Aziende con price/sales simili a Abiomed
- Hibernia REIT Plc ha Price/Sales di 16.01
- Stampede Capital ha Price/Sales di 16.01
- StarPower Semiconductor ha Price/Sales di 16.02
- Creative Eye ha Price/Sales di 16.05
- 3i Infotech ha Price/Sales di 16.07
- PIMCO Corporate & Income Strategy Fund ha Price/Sales di 16.10
- Abiomed ha Price/Sales di 16.10
- Beijing Hotgen Biotech Co ha Price/Sales di 16.10
- Wheelock and ha Price/Sales di 16.12
- Vantage Towers Ag Na O.N ha Price/Sales di 16.14
- Immobilière Dassault SA ha Price/Sales di 16.14
- WAM Leaders ha Price/Sales di 16.16
- Orthocell ha Price/Sales di 16.17